Published in J Am Heart Assoc on November 27, 2013
Percutaneous Patent Ductus Arteriosus (PDA) Closure in Very Preterm Infants: Feasibility and Complications. J Am Heart Assoc (2016) 0.79
Transcatheter closure of patent ductus arteriosus in children weighing 10 kg or less: Initial experience at Sohag University Hospital. J Saudi Heart Assoc (2015) 0.77
Iatrogenic obstruction of the aorta - a sequence of delayed, fatal complications after 'off-label' interventional persistent ductus arteriosus closure. Wideochir Inne Tech Maloinwazyjne (2016) 0.75
Amplatzer Duct Occluder for treatment of displaced PDA coil induced late haemolysis. Heart Asia (2015) 0.75
Safety, Feasibility, Results, and Economic Impact of Common Interventional Procedures in a Low-Volume Region of the United States. Pediatr Cardiol (2017) 0.75
Initial experience with the 3.3 Fr Mongoose(®) pigtail catheter for aortic angiography during patent ductus arteriosus closure in small patients. Ann Pediatr Cardiol (2017) 0.75
Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. J Am Coll Cardiol (2004) 2.86
Closure of the patent ductus arteriosus with the amplatzer PDA device: immediate results of the international clinical trial. Catheter Cardiovasc Interv (2000) 2.57
Transcatheter occlusion of the patent ductus arteriosus with Cook detachable coils. Heart (1996) 1.91
Transcatheter closure with single or multiple Gianturco coils of patent ductus arteriosus in infants weighing < or = 8 kg: retrograde versus antegrade approach. Am Heart J (1996) 1.75
Forty-six years of patient ductus arteriosus division at Children's Memorial Hospital of Chicago. Standards for comparison. Ann Surg (1994) 1.70
Catheterization for Congenital Heart Disease Adjustment for Risk Method (CHARM). JACC Cardiovasc Interv (2011) 1.47
Percutaneous closure of patent ductus arteriosus: a multiinstitutional registry comparing multiple devices. Catheter Cardiovasc Interv (2010) 1.36
Trans-catheter closure of patent ductus arteriosus-What is the best device? Catheter Cardiovasc Interv (2010) 1.35
Outcomes of transcatheter occlusion of patent ductus arteriosus in infants weighing ≤ 6 kg. JACC Cardiovasc Interv (2010) 1.25
Adverse event rates in congenital cardiac catheterization: a new understanding of risks. Congenit Heart Dis (2008) 1.21
Transcatheter closure of moderate-to-large patent ductus arteriosus in infants using Amplatzer duct occluder. Circ J (2009) 1.11
The role of surgical ligation of patent ductus arteriosus in the era of the Rashkind device. Ann Thorac Surg (1997) 1.11
Complications after transcatheter closure of patent ductus arteriosus. J Korean Med Sci (2007) 1.05
Surgical management of patent ductus arteriosus. A review of 413 cases. J R Coll Surg Edinb (1989) 1.02
Youth risk behavior surveillance--United States, 2013. MMWR Surveill Summ (2014) 6.17
hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res (2008) 4.84
Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest (2010) 2.89
Transcatheter device closure of atrial septal defects: a safety review. JACC Cardiovasc Interv (2013) 2.62
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4). Blood (2012) 2.21
Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial. Lancet Infect Dis (2013) 2.17
Adverse event rates in congenital cardiac catheterization - a multi-center experience. Catheter Cardiovasc Interv (2010) 2.15
Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res (2002) 2.13
Bronchoscopic guidance of endovascular stenting limits airway compression. Catheter Cardiovasc Interv (2014) 2.07
Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression. Immunity (2012) 1.82
Aortic valvuloplasty in the fetus: technical characteristics of successful balloon dilation. J Pediatr (2005) 1.73
The use of nonhuman primate models in HIV vaccine development. PLoS Med (2008) 1.73
Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica (2009) 1.65
Characterization of radiation exposure and effect of a radiation monitoring policy in a large volume pediatric cardiac catheterization lab. Catheter Cardiovasc Interv (2011) 1.63
Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review. Environ Health Perspect (2002) 1.60
Late pulmonary valve replacement in patients with pulmonary atresia and intact ventricular septum: a case-matched study. Ann Thorac Surg (2011) 1.60
Low weight as an independent risk factor for adverse events during cardiac catheterization of infants. Catheter Cardiovasc Interv (2013) 1.59
The gene Sr33, an ortholog of barley Mla genes, encodes resistance to wheat stem rust race Ug99. Science (2013) 1.55
Closure of perimembranous ventricular septal defects with aneurysmal tissue using the Amplazter Duct Occluder I: lessons learned and medium term follow up. Catheter Cardiovasc Interv (2012) 1.54
The frequency of cardiac arrests in patients with congenital heart disease undergoing cardiac catheterization. Anesth Analg (2014) 1.51
Catheterization for Congenital Heart Disease Adjustment for Risk Method (CHARM). JACC Cardiovasc Interv (2011) 1.47
Adverse events rates and risk factors in adults undergoing cardiac catheterization at pediatric hospitals--results from the C3PO. Catheter Cardiovasc Interv (2013) 1.46
Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection. Blood (2003) 1.44
Radiation safety program for the cardiac catheterization laboratory. Catheter Cardiovasc Interv (2011) 1.42
Comparison of surgical, stent, and balloon angioplasty treatment of native coarctation of the aorta: an observational study by the CCISC (Congenital Cardiovascular Interventional Study Consortium). J Am Coll Cardiol (2011) 1.39
Obstruction of the superior vena cava after neonatal extracorporeal membrane oxygenation: association with chylothorax and outcome of transcatheter treatment. Pediatr Crit Care Med (2013) 1.37
X-ray crystal structure of the liver X receptor beta ligand binding domain: regulation by a histidine-tryptophan switch. J Biol Chem (2003) 1.33
Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy. Breast Cancer Res Treat (2010) 1.31
Differential gamma-herpesvirus distribution in distinct anatomical locations and cell subsets during persistent infection in mice. J Immunol (2003) 1.30
Procedure-type risk categories for pediatric and congenital cardiac catheterization. Circ Cardiovasc Interv (2011) 1.23
Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction. Arthritis Rheum (2007) 1.15
Irreversible intrapulmonary vascular changes after pulmonary vein stenosis complicating catheter ablation for atrial fibrillation. Cardiovasc Pathol (2007) 1.13
Stenting of aortic coarctation: acute, intermediate, and long-term results of a prospective multi-institutional registry--Congenital Cardiovascular Interventional Study Consortium (CCISC). Catheter Cardiovasc Interv (2010) 1.12
Intervention for recoarctation in the single ventricle reconstruction trial: incidence, risk, and outcomes. Circulation (2013) 1.10
A combined sEMG and accelerometer system for monitoring functional activity in stroke. IEEE Trans Neural Syst Rehabil Eng (2009) 1.10
Cleft mitral valve without ostium primum defect: anatomic data and surgical considerations based on 41 cases. Ann Thorac Surg (2003) 1.09
Experimental quantum simulations of many-body physics with trapped ions. Rep Prog Phys (2012) 1.09
Early establishment of gamma-herpesvirus latency: implications for immune control. J Immunol (2005) 1.09
Protein aggregates and novel presenilin gene variants in idiopathic dilated cardiomyopathy. Circulation (2010) 1.08
Endomyocardial biopsy and selective coronary angiography are low-risk procedures in pediatric heart transplant recipients: results of a multicenter experience. J Heart Lung Transplant (2011) 1.06
Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia. Arthritis Res Ther (2004) 1.04
Fused video and ultrasound images for minimally invasive partial nephrectomy: a phantom study. Med Image Comput Comput Assist Interv (2010) 1.02
Ventricular function deteriorates with recurrent coarctation in hypoplastic left heart syndrome. Ann Thorac Surg (2008) 1.02
Endothelial progenitor cells, angioblasts, and angiogenesis--old terms reconsidered from a current perspective. Trends Cardiovasc Med (2008) 1.02
Virtual reality-enhanced ultrasound guidance: a novel technique for intracardiac interventions. Comput Aided Surg (2008) 1.00
Callers' experiences of contacting a national suicide prevention helpline: report of an online survey. Crisis (2012) 0.98
Safety and efficacy of balloon pulmonary valvuloplasty: a multicenter experience. Catheter Cardiovasc Interv (2012) 0.98
Salmonella enterica serotype Bredeney: antimicrobial susceptibility and molecular diversity of isolates from Ireland and Northern Ireland. Appl Environ Microbiol (2002) 0.97
Incidence and management of life-threatening adverse events during cardiac catheterization for congenital heart disease. Pediatr Cardiol (2013) 0.97
Comment on "Failure of bone marrow cells to transdifferentiate into neural cells in vivo". Science (2003) 0.96
Balloon angioplasty and stenting of branch pulmonary arteries: adverse events and procedural characteristics: results of a multi-institutional registry. Circ Cardiovasc Interv (2011) 0.95
Community use of the amplatzer atrial septal defect occluder: results of the multicenter MAGIC atrial septal defect study. Pediatr Cardiol (2008) 0.95
Device therapy for atrial septal defects in a multicenter cohort: acute outcomes and adverse events. Catheter Cardiovasc Interv (2014) 0.94
Analysis of outcome in 298 extremely low-birth-weight infants with patent ductus arteriosus. J Pediatr Surg (2009) 0.94
Outcomes after primary transcatheter therapy in infants and young children with severe bilateral peripheral pulmonary artery stenosis. Circ Cardiovasc Interv (2013) 0.93
Bare metal stenting for obstructed small diameter homograft conduits in the right ventricular outflow tract. Catheter Cardiovasc Interv (2012) 0.92
Reproducibility of echocardiographic diagnosis of left ventricular noncompaction. J Am Soc Echocardiogr (2011) 0.92
Quality metrics in cardiac catheterization for congenital heart disease: utility of 30-day mortality. Catheter Cardiovasc Interv (2014) 0.91
Bloodstream infections occurring in patients with percutaneously implanted bioprosthetic pulmonary valve: a single-center experience. Circ Cardiovasc Interv (2013) 0.90
Disease progression after bone marrow transplantation in a model of multiple sclerosis is associated with chronic microglial and glial progenitor response. J Neuropathol Exp Neurol (2007) 0.89
Regression of pulmonary arteriovenous malformations after transcatheter reconnection of the pulmonary arteries in patients with unidirectional Fontan. Congenit Heart Dis (2008) 0.88
Don't sell social science short. Science (2006) 0.87
A SYBR green-based real-time PCR method for detection of haemopoietic chimerism in allogeneic haemopoietic stem cell transplant recipients. Eur J Haematol (2006) 0.87
Adverse events associated with neonatal exchange transfusion in the 1990s. J Pediatr (2004) 0.87
Diagnostic accuracy of SeptiFast multi-pathogen real-time PCR in the setting of suspected healthcare-associated bloodstream infection. Intensive Care Med (2014) 0.86
Evaluation of pseudorabies virus as a gene transfer vector and an oncolytic agent for human tumor cells. Anticancer Res (2002) 0.86
Left ventricular remodeling and improvement in diastolic function after balloon aortic valvuloplasty for congenital aortic stenosis. Circ Cardiovasc Interv (2012) 0.85
HAnd Suture Versus STApling for Closure of Loop Ileostomy (HASTA Trial): results of a multicenter randomized trial (DRKS00000040). Ann Surg (2012) 0.85
Relationship between procedural adverse events associated with cardiac catheterization for congenital heart disease and operator factors: results of a multi-institutional registry (C3PO). Catheter Cardiovasc Interv (2013) 0.84
IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers. Cytokine (2010) 0.84
Utility of exercise stress echocardiography in pediatric cardiac transplant recipients: a single-center experience. J Heart Lung Transplant (2012) 0.84
Dynamic 2D ultrasound and 3D CT image registration of the beating heart. IEEE Trans Med Imaging (2009) 0.84
Synthetic gauge fields for vibrational excitations of trapped ions. Phys Rev Lett (2011) 0.83
In situ fracture of stents implanted for relief of pulmonary arterial stenosis in patients with congenitally malformed hearts. Cardiol Young (2008) 0.83
Risk factors for profuse systemic-to-pulmonary artery collateral burden in hypoplastic left heart syndrome. Am J Cardiol (2013) 0.83
Home visiting and child health surveillance attendance. Community Pract (2005) 0.82
Acute outcomes after introduction of a standardized clinical assessment and management plan (SCAMP) for balloon aortic valvuloplasty in congenital aortic stenosis. Congenit Heart Dis (2013) 0.82
Bevacizumab efficacy in metastatic colorectal cancer is dependent on primary tumor resection. Ann Surg Oncol (2014) 0.82
Detection of drug effects on gastric emptying and contractility using a wireless motility capsule. BMC Gastroenterol (2014) 0.81
Hepatic arterial infusion of gemcitabine plus oxaliplatin as second-line treatment for locally advanced intrahepatic cholangiocarcinoma: preliminary experience. Chemotherapy (2014) 0.81
Subject-specific models for image-guided cardiac surgery. Phys Med Biol (2008) 0.81
Evaluation of model-enhanced ultrasound-assisted interventional guidance in a cardiac phantom. IEEE Trans Biomed Eng (2010) 0.81
Acute outcome of stent therapy for coarctation of the aorta: results of the coarctation of the aorta stent trial. Catheter Cardiovasc Interv (2013) 0.80
Ultra-high-pressure balloon angioplasty for treatment of resistant stenoses within or adjacent to previously implanted pulmonary arterial stents. Circ Cardiovasc Interv (2008) 0.80
A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis. Br J Haematol (2012) 0.80
Contrast administration in pediatric cardiac catheterization: dose and adverse events. Catheter Cardiovasc Interv (2009) 0.79
Augmented reality laser projection device for surgery. Stud Health Technol Inform (2004) 0.79